Stock Events

Stock Events

LENSAR 

$5.87
5
-$0.02-0.34% Today

Statistics

Day High
5.87
Day Low
5.87
52W High
14.31
52W Low
5.35
Volume
685
Avg. Volume
103,716
Mkt Cap
70.12M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7MayExpected
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Next
-2.32
-1.48
-0.65
0.19
Expected EPS
0.185
Actual EPS
N/A

Financials

-58.71%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
106.99MRevenue
-62.81MNet Income

Analyst Ratings

$10.00Average Price Target
The highest estimate is 10.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LNSR. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap585.7B
Johnson & Johnson, through its subsidiary AMO, competes in the ophthalmic surgery market, offering products that rival LENSAR's laser systems.
Novartis
NVS
Mkt Cap297.32B
Novartis, owning Alcon, provides advanced technology for eye care and cataract surgery, directly competing with LENSAR's offerings.
Abbvie
ABBV
Mkt Cap369.39B
AbbVie, after acquiring Allergan, competes in the eye care space with a range of products that can be used alongside or in competition with LENSAR's technologies.
Bausch Health Companies
BHC
Mkt Cap1.99B
Bausch Health Companies, through its eye health division, offers products and solutions that compete in the broader ophthalmic surgical market.
Staar Surgical
STAA
Mkt Cap1B
STAAR Surgical Company specializes in implantable lenses and related ophthalmic products, competing in the cataract surgery market.
Integra Lifesciences
IART
Mkt Cap725.6M
Integra LifeSciences offers products for ophthalmic surgery, potentially competing with LENSAR in the surgical instruments sector.
Cooper Companies
COO
Mkt Cap13.69B
The Cooper Companies, through its CooperVision segment, competes in the eye care market, albeit more focused on contact lenses, it represents competition in the broader ophthalmology space.
Penumbra
PEN
Mkt Cap12.96B
Penumbra, Inc. focuses on innovative medical devices, including those for neuro and peripheral vascular conditions, and could indirectly compete with LENSAR in the medical device innovation sector.
Intuitive Surgical
ISRG
Mkt Cap160.56B
Intuitive Surgical, known for its da Vinci surgical systems, competes in the high-tech surgical equipment market, offering advanced alternatives to traditional surgery methods, including ophthalmology.

About

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.
Show more...
CEO
Mr. Nicholas T. Curtis
Employees
140
Country
US
ISIN
US52634L1089

Listings

XNAS
US
LNSR
BOATS
BOATS
LNSR.BOATS

0 Comments

Share your thoughts

FAQ

What is LENSAR stock price today?▼
The current price of LNSR is $5.87 USD — it has decreased by -0.34% in the past 24 hours. Watch LENSAR stock price performance more closely on the chart.
What is LENSAR stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange LENSAR stocks are traded under the ticker LNSR.
Is LENSAR stock price growing?▼
LNSR stock has fallen by -1.17% compared to the previous week, the month change is a -50.08% fall, over the last year LENSAR has showed a -57.19% decrease.
What is LENSAR market cap?▼
Today LENSAR has the market capitalization of 70.12M
When is the next LENSAR earnings date?▼
LENSAR is going to release the next earnings report on May 07, 2026.
What were LENSAR earnings last quarter?▼
LNSR earnings for the last quarter are -0.31 USD per share, whereas the estimation was -0.05 USD resulting in a -543.15% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is LENSAR revenue for the last year?▼
LENSAR revenue for the last year amounts to 106.99M USD.
What is LENSAR net income for the last year?▼
LNSR net income for the last year is -62.81M USD.
How many employees does LENSAR have?▼
As of April 07, 2026, the company has 140 employees.
In which sector is LENSAR located?▼
LENSAR operates in the Health Care sector.
When did LENSAR complete a stock split?▼
LENSAR has not had any recent stock splits.
Where is LENSAR headquartered?▼
LENSAR is headquartered in Orlando, US.